Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsInitiationPrice Target
Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.
Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.